Loading...

EW EDWARDS LIFESCIENCES CORP Disposals and divestitures 8-K Filing

DWRD

W

EDWARDS LIFESCIENCES CORP

(EW)

2024 8-K

Financial Results Report

Acquisition Blocked

CFO Transition Notice

Q3 Earnings Report

Share Buyback Announcement

Financial Statements

Employee Stock Purchase Pla...

Financial Statements

Q4 2024 Results

Q3 Financial Results

Financial Results and Acqui...

Acquisition of Innovalve Bi...

Appointment of Director

Retirement and Succession

Stock and Asset Purchase Ag...

Annual Meeting Results

Financial Results

Management Changes

Financial Results

Spin-off and Share Repurcha...

Earnings Reports

Financial Results

Salary Increase and Amendme...

Financial Results

Bylaws Amendment

Financial Results

External Links:

Edwards Lifesciences Corporation has completed the sale of its Critical Care product group to Becton, Dickinson and Company and announced a $1.5 billion share repurchase authorization along with a $500 million accelerated share repurchase agreement.

AI Assistant

EDWARDS LIFESCIENCES CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.